Apimeds Pharmaceuticals US, Inc (APUS) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Apimeds Pharmaceuticals US, Inc (APUS).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $1.57

Daily Change: -$0.13 / 8.28%

Daily Range: $1.56 - $1.73

Market Cap: $18,174,320

Daily Volume: 91,844

Performance Metrics

1 Week: -9.77%

1 Month: -12.29%

3 Months: -58.38%

6 Months: -58.38%

1 Year: -58.38%

YTD: -28.64%

Company Details

Employees: 2

Sector: Health technology

Industry: Biotechnology

Country:

Details

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey.

Selected stocks

Helmerich & Payne, Inc. (HP)

National Storage Affiliates Trust (NSA)

Nuveen Missouri Quality Municipal Income Fund (NOM)